Is Novo Nordisk A/S (NVO) A Good Biotech Stock to Buy?
We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds. In this article, we are ...
Novo Nordisk Files Patent Claims to Fend off Generic Rivals of Wegovy
Sun Pharma of India and Mylan Pharmaceuticals of West Virginia seek FDA approval of generic versions of the popular ...
Eli Lilly Makes Strides on Weekly Insulin Shot as Novo Nordisk Stumbles
Today, patients on insulin receive injections daily, or even more often, but both companies are working to change that.
Kepler Capital Sticks to Their Hold Rating for Novo Nordisk (0QIU)
Kepler Capital analyst David Evans maintained a Hold rating on Novo Nordisk (0QIU – Research Report) on September 6 and set a price ...
What the Options Market Tells Us About Novo Nordisk
Out of all of the special options we uncovered, 7 are puts, for a total amount of $295,009, and 5 are calls, for a total ...
The Motley Fool8d
These 3 Factors Could Make Eli Lilly Stock a Better Buy Than Novo Nordisk Right Now
Eli Lilly and Novo Nordisk compete in a handful of different markets. Novo Nordisk is scaling up its output and ...
STAT9d
New Wegovy analysis could boost Novo Nordisk’s bid to expand drug’s label in heart failure
Novo Nordisk’s Wegovy cut the risk of severe complications in patients with a common form of heart failure, according to a ...
Novo to Contribute Half Danish GDP Growth in 2024, Danske Says
Novo Nordisk A/S is likely to contribute about half of Denmark’s economic expansion this year, helping the nation to ...
Novo Nordisk Reduces Price of Popular Obesity Drug Amid Rising Competition
Novo Nordisk is working to resolve supply issues that are affecting the launch of its weight-loss and diabetes medications, ...